Kongo Review
Best for: Low-cost compounded semaglutide or tirzepatide nationwide with no membership and everything included
Kongo (Kongo Health Inc.) is a transparent, no-membership telehealth platform offering compounded GLP-1 weight-loss medication in all 50 states: compounded semaglutide at $119/month and tirzepatide at $229/month, with the provider visit, supplies, and free shipping always included. A 4-minute intake (no video call) gets a licensed-provider decision within 24 hours; prescriptions are compounded by a licensed US pharmacy. Kongo also offers longevity treatments (NAD+, sermorelin). It carries verifiable LegitScript certification; compounded meds are not FDA-approved.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Kongo stands out for its medical oversight and pharmacy verification.
Kongo at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $119/mo ($119/mo; provider visit, supplies, and free shipping always included; no membership fee. 3-month plans available.)
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Kongo
Each dimension is scored algorithmically from Kongo’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.4/10Kongo does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit.
Effectiveness25%
9.2/10Kongo offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.5/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
9.2/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-28).
Accessibility10%
9.4/10Kongo treats patients in all 50 states.
Support10%
7.0/10Kongo provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Kongo review
Last checked 2026-06-28- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Kongo offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
$119/mo; provider visit, supplies, and free shipping always included; no membership fee. 3-month plans available.
$229/mo; provider, supplies, and free shipping always included; no membership. Also offers NAD+, sermorelin, glutathione.
Ready to get started?
Plans and promotions change often — check Kongo's current pricing and active discounts before you decide.
What we like
- Among the lowest compounded GLP-1 prices: semaglutide $119/month and tirzepatide $229/month
- Available in all 50 states with no membership fee, and provider, supplies, and free shipping always included
- Verifiable LegitScript certification (seal ID 45229340)
- Fast and simple: 4-minute intake with no video call and provider approval within 24 hours
- Also offers longevity treatments (NAD+, sermorelin, glutathione) if you want more than GLP-1
Watch-outs
- Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- The compounding pharmacy is described only as a 'licensed US pharmacy' and not named
- Newer brand; member testimonials are the main social proof
- Some verticals (Longevity, Intimacy) are still listed as 'coming soon'
Is Kongo worth it? Our verdict
Kongo positions itself around one thing: Low-cost compounded semaglutide or tirzepatide nationwide with no membership and everything included. It treats patients in all 50 states, so access isn't a barrier.
How much Kongo actually costs
Kongo doesn't post a standard monthly cash price publicly. Start a consultation to get an exact quote, and confirm the ongoing rate — not just any first-month offer — before you commit.
Medications: what Kongo prescribes
Kongo prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who Kongo is best for — and who should skip it
A good fit if you…
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Kongo treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Kongo could be worth a look, but it doesn't publish a standard price up front — get a quote and confirm the ongoing rate before deciding, and compare it against the alternatives below.
Ready to start with Kongo?
Starting at $119/month. See current pricing and start your free consultation.
Alternatives to Kongo
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Kongo review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Kongo?
Starting at $119/month. See current pricing and start your free consultation.